On heels of Amgen lawsuit, FTC broadens investigation of PBMs
The regulator is probing the business practices of two more drug purchasing organizations, deepening an investigation that began last year.
On heels of Amgen lawsuit, FTC broadens investigation of PBMs Read More »
